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1. Introduction 
Aminoacyl-tRNA ligases play a crucial role in pro- 
tein synthesis. Each enzyme esterifies one of the 
amino acids to the corresponding tRNAin the presence 
of ATP and Mg*‘. Periodate-oxidized tRNA is often 
used as a deadend inhibitor in kinetic studies in this 
class of enzymes [l-5]. With the arginyl-tRNA ligase 
from Escherichia coli K12 we observed apparent 
mixed-type non-competitive inhibition with tRNA as 
the variable substrate. We also demonstrated an 
irreversible inactivation of the enzyme upon preincu- 
bation with periodate-oxidized tRNA. This finding 
indicates that special attention has to be paid to the 
interpretation of inhibition patterns obtained with 
this inhibitor. 
2. Materials and methods 
2.1. Arginyl-tRNA ligase 
The enzyme was purified from crude extracts of 
E. coli K12. Details of the procedure followed will be 
published elsewhere. The purity of the preparation 
was 2 95% based on polyacrylamide gel electrophoresis. 
The specific activity was determined to be 50 000 units/ 
mg, under the conditions defined in [6]. 
2.2. tRNA and periodate-oxidized tRNA 
Crude tRNA was isolated from E. coli K12 by 
phenol extraction followed by DEAEcellulose chro- 
matography [7] and stripping [8]. tRNA with the 
3’-terminal cis-diol group oxidized by periodate to a 
dialdehyde function was prepared as in [9]. 
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2.3. Aminoacylation assay 
The catalytic activity of arginyl-tRNA ligase was 
assayed under optimum conditions for aminoacyla- 
tion of tRNA (1 mg/ml) at 37°C in 100 ~1 or 200 ~1 
containing 0.1 M N-2-hydroxyethylpiperazine-N’-2- 
ethanesulfonic acid (Hepes)-NaOH buffer (pH 8.35), 
6.5 mM MgC12, 2.5 mM ATP and 12.5 FM [‘“cl- 
arginine, except for fig.1. The kinetic experiments 
illustrated fig.1 were performed at pH 7.4 in order to 
reduce the nonenzymatic hydrolysis of arginyl-tRNA 
which cannot be neglected at pH 8.35. The fixed 
substrate concentrations were chosen about equal to 
the Km values. At pH 7.4 the optimum MgC12 con- 
centration was determined to be 1.5 mM in excess 
over ATP, instead of 4 mM at pH 8.35. Enzyme con- 
centrations and times of incubation were chosen so 
that the measured activity was proportional to the 
concentration of active synthetase. Samples for liquid 
scintillation counting were prepared as described [6]. 
2.4. Inactivation of arginyl-tRNA ligase 
Kinetics of inactivation were followed at 37°C or 
50°C in 0.1 M Hepes-NaOH buffer (pH 7.4) con- 
taining 1.5 mM MgCl*, 10 PM dithioerythritol and 
50 pg/ml serum albumin, unless otherwise mentioned. 
Aliquots of the incubation mixtures were withdrawn 
at timed intervals and assayed directly as in section 
2.3, using the aminoacylation assay. 
3. Results 
Figure 1 shows that periodate-oxidized tRNA 
apparently gives mixed type non-competitive inhibi- 
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Fig.1. Double-reciprocal plot of arginylation of tRNA in 
absence (0) and in presence of periodate-oxidized tRNA: (*) 
0.28 mg/mI; (v) 0.84 mgjml). Data were obtained from the. 
initial velocity of the aminoacylation assay: 0.1 M Hepes- 
NaOH (pH 7.4),2.5 PM [Y]arginine,0.95 mM ATP, 2.45 mM 
MgCI,, 0.1-0.9 mg/ml tRNA. Enzyme concentration was 
2.2 ng/200 ~1 assay. Incubation for 2.5 min at 37°C. 
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Fig.2. Time-dependent inactivation of arginyl-tRNA ligase 
at 37°C; (0) 11.2 ng/ml ligase in 0.5 mt buffer; (4) 11.2 ng/ml 
ligase in 0.5 mi buffer with 0.7 m&l periodate-oxidized 
tRNA; (A) 112 ng/ml ligase in 0.1 ml buffer with 7.1 mg/ml 
periodatc-oxidized tRNA; after 45 min (indicated by the 
arrow) the enzyme was diluted 50-fold with 0.1 M Hepes- 
NaOH buffer (pH 7.4), containing 0.2 mg/ml serum albumin 
and 1 mM dithioerythritol, and allowed to stand at 24°C. 
tion with respect to tRNA in the arginyl-tRNA ligase 
system. The experiment was repeated several times 
and the double-reciprocal plots, calculated using the 
least square method, always intersected to the left of 
the l/v axis. 
Following this observation we investigated the 
effect of a preincubation of the Iigase with the inhibitor 
on catalytic activity. It is obvious that if an inactiva- 
tion of the enzyme occurs by reaction with the 
inhibitor during the assay, the concentration of active 
enzyme will be decreased in the experiments in which 
periodate-oxidized tRNAisadded, causing the double- 
reciprocal plots not to intersect on the ordinate. 
Figure 2 demonstrates that at 37°C indeed such an 
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Fig.3. Heat inactivation of arginyl-tRNA ligase. The enzyme 
(0.6 fig/ml) was incubated in 0.5 ml 0.01 M Tris-HCI buffer 
(pH 7.4). containing 0.1 mM dithioerythritol at the tempera- 
tures indicated. (A) Arrhenius plot: the activation energy for 
the process, calculated with the firsterder rate constants (k) 
of the decay curves in the region 45 -55°C is 85 kcal/mol. 
(B) The percentage of the activity remaining after 2 min incu- 
bation at different temperatures; (A) serum albumin (0.1 mg/ 
ml) added. 
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inactivation occurs. Practically no loss of enzymatic 
activity is observed in the absence of the inhibitor or 
in the presence of untreated tRNA. When the inacti- 
vated synthetase was diluted with 50 vol. buffer, no 
recovery of activity could be demonstrated, neither 
by incubation at 0°C nor at 24°C. 
At 50°C periodate-oxidized tRNA was found [IO] 
protected to the same extent as untreated tRNA the 
ability of arginyl-tRNA ligase from E. coli B to catalyze 
an ATP-PP, exchange. As can be seen from fig.3, the 
aminoacylation activity of arginyl-tRNA ligase from 
E. coli K12 is rapidly lost at 5O’C. Serum albumin 
protects the enzyme against thermal inactivation, 
possibly by eliminating wall effects. tRNA specifically 
protects the enzyme [IO]. We observed protection 
of enzymatic activity upon incubation at 50°C by 
periodate-oxidized tRNA as in [lo], but to a much 
lower degree than is obtained with untreated tRNA 
at the same concentration which is assumed to saturate 
the enzyme (fig.4). 
Table I shows the effect of the substrates of the 
enzyme on the inactivation process. High concentra- 
tions of tRNA and ATP clearly protect the enzyme 
against inactivation by periodate-oxidized tRNA; 
arginine on the other hand does not exhibit measurable 
protective effects. 
TIME (min> 
Fig.4. Timedependent inactivation of arginyl-tRNA ligase 
(11.2 ng/ml) at 50°C in 0.5 ml buffer in the presence of 
0.28 mg/ml tRNA (X), 0.28 mg/ml periodateaxidized tRNA 
(A) and without any tRNA (e). 
Table 1 
Effect of substrateson the inactivation of vinyl-tRNA 
ligase (11.2 ngfml) by periodate-oxidized tRNA at 37°C 
Additions % act. 
Oxidized tRNA tRNA Arginine Mg”-ATPa 
fmglml) (n&ml) WI (mM) 
- - _ _ 93.4 
- 0.28 - - 95.8 
0.7 _ 59.8 
0.1 0.28 - - 66.0 
0.7 2.8 - - 87.1 
0.7 - 3.0 - 66.0 
0.7 - 25 - 60.6 
0.7 - 1.3 68.3 
0.7 - _ 9.7 81.8 
a Added as an equimolar mixture of ATP and MgC1, 
The activity remaining after 30 min incubation was deter- 
mined and is expressed as % of the original activity 
4. Discussion 
The experiments reported here demonstrate that 
periodateoxidized tRNA not only inhibits the amino- 
acylation reaction catalyzed by ar~nyl-t~A ligase 
by acting as a deadend inhibitor, but also inactivates 
the enzyme. Binding of periodate-oxidized tRNA to 
the enzyme in addition yields protection against 
thermal denaturation. At 37°C the enzyme is heat- 
stable and the inactivating reaction can be observed. 
At 50°C the enzyme is heat-labile and the inactivation 
by periodate-oxidized tRNA is obscured by the stabi- 
lizing effect of the binding. 
The inactivation by periodate-oxidized tRNA 
could occur through the formation of a Schiff’s base 
between the reactive dialdehyde moiety of the modi- 
fied tRNA and a functional group on the enzyme, 
such as the e-amino group of a lysine residue. The 
fact that tRNA and ATP protect the enzyme from 
inactivation supports the hypothesis that the reacting 
group is in or near the active site of the enzyme. The 
possib~ity of an interfe~ng reaction was mentioned 
in [ 1 l]. Recently, similar reactions were shown to 
occur in several other aminoacyl-tRNA ligases with 
pyridoxal 5’-phosphate [ 121 and with 2’,3’-ribose 
oxidized ATP [ 131, which were also assumed to be 
active site directed reagents. 
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The possible inactivation caused by periodate- 
treated tRNA stresses the importance of a careful 
evaluation of kinetic measurements in the presence of 
this reagent. Because of the concentration-dependent 
protection afforded by the substrates against the inac- 
tivation of arginyl-tRNA ligase, it was not possible to 
make accurate corrections for the observed reaction 
velocities. It is clear however that a mixed-type non- 
competitive inhibition pattern can be obtained unless 
the reaction conditions are such that the inactivation 
by periodate-oxidized tRNA proceeds only to a 
neglegible extent in the time period of the assay. 
On the other hand, periodate-oxidized tRNA might 
prove useful as an active site labeling agent. 
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